Shanghai Pharmaceuticals Holding Co., Ltd. (601607.SH) has announced its intention to publicly list for sale its entire 30% equity stake in the joint venture Sino-American Shanghai Squibb Pharmaceutical Co., Ltd. via a property rights exchange. The minimum listing price for the stake has been set at no less than 1.023 billion yuan. Following the completion of this transaction, the company will no longer hold any shares in Sino-American Shanghai Squibb. This divestment is not expected to have a material impact on the company's routine operations or financial standing. The move is aimed at safeguarding state-owned assets and maximizing their value, aligning with the strategic interests of the company and its shareholders.